Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Over the last few years, increased evidence has supported the role of iron dysregulation in the pathogenesis of multiple sclerosis (MS), as iron is essential for myelin formation and oxidative phosphorylation. We studied indices of iron metabolism, such as serum iron, ferritin, transferrin and soluble transferrin receptor (sTFR) levels in 27 MS patients. Seven patients had chronic progressive active disease (CP-A), six had chronic progressive stable (CP-S), ten had relapsing—remitting active (RR-A) and four had relapsing—remitting stable (RR-S) disease. sTFR levels were found to be significantly higher in CP-A (P=0.021) and RR-A (P= 0.004) patients than in controls. sTFR levels were also elevated in CP-S patients but did not reach significance (P=0.064). sTFR values in RR-S patients were comparable to those found in controls (P=0.31). Ferritin levels were significantly elevated only in CP-A patients (P= 0.002). Patients of the CP group had significantly higher ferritin values than the RR patients (P= 0.004). Haemoglobin values as well as iron and transferrin levels were within normal limits in all patients. In conclusion, the increased serum sTFR and ferritin levels in nonanaemic MS patients with active disease reflect the increased iron turnover. The mild elevation of sTFR levels in CP-S patients may indicate active inflammation with ongoing oxidative damage that is not detectable by history or examination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The levels were found to be significantly higher in patients with active MS, either in progressive or relapsing-remitting clinical form, than in controls.”
From The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis (2006) · cites this paper as [32]
In the citing paper
“Serum ferritin levels were also significantly elevated in patients affected by the active and progressive form.32”
From The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis (2006) · cites this paper as [32]
In the citing paper
“Both findings support the hypothesis above described, which proposes local iron overload as the initial signal of the inflammatory chain in MS.”
From The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis (2006) · cites this paper as [32]
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 600
The transferrin receptor: role in health and disease
Ponka, P., & Lok, C. N. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00070-9 · Cited by 595
The physiology of transferrin and transferrin receptors.
Huebers, H. A., & Finch, C. A. (1987) · Physiological Reviews · doi:10.1152/physrev.1987.67.2.520 · Cited by 586
Transferrin and Transferrin Receptor Function in Brain Barrier Systems
Moos, T., & Morgan, E. H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006948027674 · Cited by 394
Iron deposits in multiple sclerosis and Alzheimer's disease brains
LeVine, S. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00470-8 · Cited by 258
Iron, Transferrin, and Ferritin in the Rat Brain During Development and Aging
Roskams, A. J. I., & Connor, J. R. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020709.x · Cited by 172
Oxidative damage to DNA in plaques of MS brains
Vladimirova, O., O'Connor, J., Cahill, A., Alder, H., Butunoi, C., & Kalman, B. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400503 · Cited by 138
Research works printed but not linked: 2
- Aisen P., 1994, Iron metabolism: an evolutionary perspective, 1
- Lynch SG, 2000, Cell Mol Biol (Noisy-le-grand), 46, 865
Cited by
Kell, D. B., & Pretorius, E. (2014) · Metallomics · doi:10.1039/c3mt00347g · Cited by 667
Zamboni, P. (2006) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.99.11.589 · Cited by 239
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
Ehrenreich, H., Fischer, B., Norra, C., Schellenberger, F., Stender, N., Stiefel, M., Sirén, A.-L., Paulus, W., Nave, K.-A., Gold, R., et al. (2007) · Brain · doi:10.1093/brain/awm203 · Cited by 236
ORBACH, H., ZANDMAN‐GODDARD, G., AMITAL, H., BARAK, V., SZEKANECZ, Z., SZUCS, G., DANKO, K., NAGY, E., CSEPANY, T., CARVALHO, J. F., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.044 · Cited by 233
Chemistry and biology of ferritin
Plays, M., Müller, S., & Rodriguez, R. (2021) · Metallomics · doi:10.1093/mtomcs/mfab021 · Cited by 232
Metadata
- Authors
- Sfagos, C., Makis, A. C., Chaidos, A., Hatzimichael, E. C., Dalamaga, A., Kosma, K., & Bourantas, K. L.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- University Hospital of Ioannina (GR)
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2005-06
- Volume
- 11
- Issue
- 3
- Pages
- 272-275
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2125863155
- Cited by
- 84
- References
- 25
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 5 · 2013: 6 · 2012: 10
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- multiple sclerosis, serum ferritin, transferrin, soluble transferrin receptor, iron metabolism, iron dysregulation, iron turnover, disease activity, relapsing-remitting multiple sclerosis, chronic progressive multiple sclerosis, oxidative damage, inflammation
- MeSH terms
- Adult, Female, Ferritins, Humans, Iron, Male, Middle Aged, Receptors, Transferrin, Severity of Illness Index, Solubility, Transferrin, Biomarkers, Oxidative Stress, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients. https://app.cochat.ai/papers/10.1191/1352458505ms1171oa
- The paper
- Sfagos, C., Makis, A. C., Chaidos, A., Hatzimichael, E. C., Dalamaga, A., Kosma, K., & Bourantas, K. L. (2005). Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients. Multiple Sclerosis Journal. https://doi.org/10.1191/1352458505ms1171oa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.